HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $840,000 | +172.7% | 19,102 | +158.7% | 0.07% | +222.7% |
| Q1 2021 | $308,000 | -4.6% | 7,384 | -2.3% | 0.02% | -37.1% |
| Q4 2020 | $323,000 | -7.2% | 7,561 | -41.7% | 0.04% | -12.5% |
| Q2 2020 | $348,000 | +54.7% | 12,979 | -2.6% | 0.04% | +300.0% |
| Q2 2018 | $225,000 | -41.7% | 13,319 | -30.1% | 0.01% | -50.0% |
| Q4 2017 | $386,000 | -27.2% | 19,045 | -37.6% | 0.02% | -23.1% |
| Q3 2017 | $530,000 | – | 30,535 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |